🇪🇺 Marstacimab in European Union

Marstacimab (marstacimab) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/006240
  • Local brand name: Hympavzi
  • Status: approved

Marstacimab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Rare Disease approved in European Union

Frequently asked questions

Is Marstacimab approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Marstacimab in European Union?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.